https://www.biospace.com/eli-lilly-and-company-release-investigational-treatment-ruboxistaurin-demonstrated-promise-in-reducing-the-occurrence-of-vision-loss-caused-by-diabet
Eli Lilly and Company Release: Investigational Treatment Ruboxistaurin Demonstrated Promise In...
eli lilly and companyinvestigational treatmentrelease
https://www.jnj.com/media-center/press-releases/janssen-investigational-treatment-for-schizophrenia-shows-positive-efficacy-delays-relapse
Janssen Investigational Treatment for Schizophrenia Shows Positive Efficacy, Delays Relapse
Nov 30, 2025 - Independent Data Monitoring Committee Recommends Halting Trial and Unblinding Data Based on Treatment Efficacy
treatment for schizophreniajanssenshowspositiveefficacy
https://www.uhhospitals.org/uh-research/find-clinical-trials-and-studies/clinical-trials-search/research-study-to-evaluate-an-investigational-treatment-study-to-treat-encephalitis-12470
Research Study to Evaluate an Investigational Treatment Study to Treat Encephalitis * | University...
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Basket Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of...
research studyinvestigational treatmentevaluateencephalitisuniversity
https://atopic-dermastudy.com/
Investigational Treatment Study for Moderate-to-Severe Atopic Dermatitis (AD)
investigational treatmentatopic dermatitisstudymoderatesevere
https://www.biospace.com/abbvie-presents-new-data-for-its-investigational-hepatitis-c-treatment-in-japanese-patients-with-and-without-cirrhosis
AbbVie Presents New Data For Its Investigational Hepatitis C Treatment In Japanese Patients With...
https://www.gilead.com/news/news-details/2020/gilead-presents-additional-data-on-investigational-antiviral-remdesivir-for-the-treatment-of-covid-19
Gilead Presents Additional Data on Investigational Antiviral Remdesivir for the Treatment of...
Gilead Presents Additional Data on Investigational Antiviral Remdesivir for the Treatment of COVID 19
https://www.prweb.com/releases/company_says_investigational_drug_may_enhance_standard_mesothelioma_treatment_according_to_surviving_mesothelioma/prweb11907677.htm
Company Says Investigational Drug May Enhance Standard Mesothelioma Treatment, According to...
(PRWEB) June 05, 2014 -- Veratem, Inc., the developers of several experimental drugs that target cancer stem cells, have released an update on their ongoing...
investigational drugmesothelioma treatmentcompanysaysmay
https://www.uchicagomedicine.org/forefront/news/investigational-drug-prevents-life-threatening-side-effects-of-kidney-disease-treatment
Investigational drug prevents life-threatening side effects of kidney disease treatment - UChicago...
investigational druglife threateningside effects
https://www.biospace.com/statera-biopharma-submits-phase-3-clinical-trial-protocol-to-fda-for-investigational-treatment-of-pediatric-crohn-s-disease
Statera Biopharma Submits Phase 3 Clinical Trial Protocol to FDA for Investigational Treatment of...
Dec 29, 2021 - Statera Biopharma, Inc. today announced submission to the U.S. Food and Drug Administration (FDA) of its Phase 3 clinical trial protocol for STAT-201 in the...
phase 3 clinical trial
https://www.biospace.com/fda-accepts-new-drug-application-for-investigational-compound-dapagliflozin-for-the-treatment-of-type-2-diabetes
FDA Accepts New Drug Application for Investigational Compound Dapagliflozin for the Treatment of...
new drug application
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-06240&r=1
An Investigational Scan (89Zr-DFO-Girentuximab PET/CT) for Determining the Treatment Effects of...
An Investigational Scan (89Zr-DFO-Girentuximab PET/CT) for Determining the Treatment Effects of Belzutifan in Patients with Advanced Clear Cell Renal Cell...
https://www.takeda.com/en-us/newsroom/news-releases/20102/takeda-initiates-cardiovascular-outcomes-trial-for-alogliptin-an-investigational-treatment-for-type-2-diabetes/
Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin, An Investigational Treatment for...
Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin, An Investigational Treatment for Type 2 Diabetes
takedainitiatescardiovascularoutcomestrial